Clinical trial
Rifampin Drug-Drug Interaction Study With Lurasidone HCl
NCT01082276 is registered in ClinicalTrials.gov with Sumitomo Pharma America, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rifampin Drug-Drug Interaction Study With Lurasidone HCl
- Lead sponsor
- Sumitomo Pharma America, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 31, 2008
- Completion date
- August 31, 2008
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
male, healthy normal subjects